HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the bronchodilator effects of aerosol fenoterol and isoproterenol.

Abstract
Aerosolized fenoterol in a dosage of 400 microgram was compared to isoproterenol 150 microgram in 31 asthmatic subjects during the course of a double-blind parallel 90-day study. Bronchodilator activities of the two drugs were evaluated for up to 6 hours on days 1, 45 and 90. Analysis of the data revealed that fenoterol consistently produced a significantly greater increase in FEV1, FEF25-75% and Gaw/VL. Specific airway conductance increased on each test day 25 percent or more above baseline for over three hours after use of fenoterol and for only one hour after use of isoproterenol. Fenoterol has less effect upon the cardiovascular and central nervous systems, but produced a greater incidence of shaking compared to isoproterenol. Patients used fenoterol less frequently than isoproterenol which can be attributed to the former having a greater peak effect and time course of bronchodilation. The therapeutic efficacy of fenoterol was sustained throughout this three-month study, and suggests that this relatively selective beta2 adrenergic drug will provide a well tolerated, alternative aerosol for chronic use in asthma.
AuthorsS N Steen, R Smith, J Kuo, I Ziment, G N Beall
JournalChest (Chest) Vol. 72 Issue 6 Pg. 724-30 (Dec 1977) ISSN: 0012-3692 [Print] United States
PMID336305 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Aerosols
  • Ethanolamines
  • Fenoterol
  • Isoproterenol
Topics
  • Adult
  • Aerosols
  • Aged
  • Asthma (drug therapy)
  • Bronchi (drug effects)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Ethanolamines (administration & dosage)
  • Female
  • Fenoterol (administration & dosage, adverse effects, pharmacology, therapeutic use)
  • Forced Expiratory Volume
  • Humans
  • Isoproterenol (administration & dosage, adverse effects, pharmacology, therapeutic use)
  • Lung (physiopathology)
  • Male
  • Maximal Midexpiratory Flow Rate
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: